CASI PHARMACEUTICALS, INC. Cash and Cash Equivalents
CASI PHARMACEUTICALS, INC. (CASIF) had Cash and Cash Equivalents of $5.63 million as of 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-05-15
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $5.63M.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value $13.47M.
- 2023-12-31: Cash and Cash Equivalents, at Carrying Value $17.08M.
- 2022-12-31: Cash and Cash Equivalents, at Carrying Value $47.11M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-12-31 | $5.63M 20-F · filed 2026-05-15 |
| 2024-12-31 | $13.47M 20-F · filed 2026-05-15 |
| 2023-12-31 | $17.08M 20-F · filed 2025-03-31 |
| 2022-12-31 | $47.11M 20-F · filed 2024-03-28 |
| 2021-12-31 | $38.70M 20-F · filed 2023-04-26 |